Pro12Ala polymorphism of peroxisome proliferator activated receptor gamma 2 may be associated with adverse neurodevelopment in European preterm babies. Issue 8 (21st June 2021)

• Record Type: Journal Article
• Authors: Victor, Suresh; Chew, Andrew; Falconer, Shona
• Is Part Of: Brain and behavior. Volume 11:Issue 8(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-06-21
• Subjects: brain -- cognition -- genetic -- infant -- newborn -- PPAR gamma -- single‐nucleotide polymorphism; Neurology -- Periodicals; Neurosciences -- Periodicals; Psychology -- Periodicals; Psychiatry -- Periodicals; 616.8005
• DOI: 10.1002/brb3.2256
• Languages: English
• ISSNs: 2162-3279

Abstract

Abstract: Introduction: Prematurity is the leading cause of death and disability in children under 5 years of age. Understanding the molecular mechanisms of the biological processes involved in preterm brain injury may help develop novel neuroprotective treatment strategies. A growing body of evidence suggest that peroxisome proliferator‐activated receptor gamma (PPARγ) signaling is associated with inhibited brain development in preterm babies. The Ala allele of the Pro12Ala polymorphism of PPARγ2 decreases receptor binding affinity and consequently induces a reduction of PPARγ signaling. Methods: In this study, we carried out a preliminary analysis of existing datasets to test the hypothesis that reduced transactivation capacity of PPARγ in the presence of the Ala variant of PPARγ2 may be associated with adverse neurodevelopment in preterm babies. The association between PPAR‐γ2 Pro12Ala polymorphism and neurodevelopment at 18–24 months of age was assessed in two groups of European infants, 155 born before 33 weeks' gestation and 180 born later than 36 weeks' gestation using a linear regression model. The Bayley Scales of Infant and Toddler Development–3rd edition was administered to assess neurodevelopment at 18–24 months of age. Results: We observed the Ala allele of the Pro12Ala polymorphism in 25% preterm infants and 20% term infants. The Ala allele of PPARγ2 was significantly associated with adverse cognitive ( p = .019), language ( p = .03), and motor development (p = 0.036) at 18–24 months of age after taking into consideration the duration of ventilation, gender, and index of multiple deprivation scores, but without correction for potential shared ancestry. There was no association between the PPAR‐γ2 Pro12Ala polymorphism and neurodevelopment in term infants. Conclusions: These preliminary data suggest that PPARγ signaling in the presence of the Ala variant of PPARγ2 may be associated with adverse neurodevelopment in preterm infants suggesting that further studies are warranted. Abstract : There are multiple definitions of hyposmia in Parkinson's disease (PD), and subtle differences between them can lead to different and often non‐comparable results. To illustrate the need for a standardised definition of hyposmia in PD, that would adjust for age and gender and account for the background decline in olfactory performance with ageing, this paper compares four published definitions of hyposmia, demonstrating the effect of each definition on the research outcomes when applied to the same cohort.